Metallothioneins: New functional and structural insights

Current Opinion in Chemical Biology

Volumn 4, Issue 2, 2000, Pages 177-183

  Vašák, Milan ^a   Hasler, Daniel W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN; ZINC;

APOPTOSIS; HOMEOSTASIS; MAMMAL; NONHUMAN; PROTEIN STRUCTURE; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REVIEW; SEA URCHIN;

ECHINOIDEA; MAMMALIA;

EID: 0038406726     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00082-X     Document Type: Review

References (64)

1. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science. 271:1996;1081-1085.
2. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev. 73:1993;79-118.
3. Zhao H., Eide D. The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation. Proc Natl Acad Sci USA. 93:1996;2454-2458.
4. Zhao H., Eide D. The ZRT2 gene encodes the low affinity zinc transporter in Saccharomyces cerevisiae. J Biol Chem. 271:1996;23203-23210.
5. Palmiter R.D., Findley S.D. Cloning and functional-characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:1995;639-649.
6. Palmiter R.D., Cole T.B., Findley S.D. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 15:1996;1784-1791.
7. Palmiter R.D., Cole T.B., Quaife C.J., Findley S.D. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci USA. 93:1996;14934-14939.
8. Huang L., Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet. 17:1997;292-297.
9. Cole T.B., Wenzel H.J., Kafer K.E., Schwartzkroin P.A., Palmiter R.D. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA. 96:1999;1716-1721.
10. Vašák M., Kägi J.H.R. Metallothioneins. King R.B. Encyclopedia of Inorganic Chemistry. 1994;2229-2241 J Wiley & Sons Ltd, New York.
11. Moffatt P., Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev. 29:1997;261-307.
12. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
13. Kägi J.H.R. Overview of metallothionein. Methods Enzymol. 205:1991;613-626.
14. Auf der Maur A., Belser T., Elgar G., Georgiev O., Schaffner W. Characterization of the transcription factor MTF-1 from the Japanese pufferfish (Fugu rubripes) reveals evolutionary conservation of heavy metal stress response. Biol Chem. 380:1999;175-185.
15. Heuchel R., Radtke F., Schaffner W. Transcriptional regulation by heavy metals, examplified at the metallothionein genes. Bäuerle P.A. Inducible Gene Expression. 1995;206-240 Birkhäuser, Boston.
16. Li Q., Hu N., Daggett M.A., Chu W.A., Bittel D., Johanson J.A., Andrews G.K. Participation of upstream stimulator factor (USF) in cadmium-induction of the mouse metallothionein-I gene. Nucleic Acids Res. 26:1998;5182-5189.
17. Rauser W.E. Phytochelatins and related peptides. Structure, biosynthesis, and function. Plant Physiol. 109:1995;1141-1149.
18. Binz P.A., Kägi J.H.R. Metallothionein: molecular evolution and classification. Klaassen C. Metallothioenein IV. 1999;7-13 Birkhäuser, Basel.
19. Dallinger R., Berger B., Hunziker P., Kägi J.H. Metallothionein in snail Cd and Cu metabolism. Nature. 388:1997;237-238.
20. 7-MTA is presented and compared with the previously determined structures of mammalian and crustacean MTs. General considerations on possible topologies of metal-thiolate clusters are made.
21. Peterson C.W., Narula S.S., Armitage I.M. 3D solution structure of copper and silver-substituted yeast metallothioneins. FEBS Lett. 379:1996;85-93.
22. 7-metallothionein. Eur J Biochem. 267:2000;1008-1018.
23. Pickering I.J., Prince R.C., George G.N., Rauser W.E., Wickramasinghe W.A., Watson A.A., Dameron C.T., Dance I.G., Fairlie D.P., Salt D.E. X-ray absorption spectroscopy of cadmium phytochelatin and model systems. Biochim Biophys Acta. 1429:1999;351-364.
24. Kang Y.J., Li G., Saari J.T. Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am J Physiol. 276:1999;H993-H997.
25. Campagne M.V., Thibodeaux H., van Bruggen N., Cairns B., Gerlai R., Palmer J.T., Williams S.P., Lowe D.G. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc Natl Acad Sci USA. 96:1999;12870-12875.
26. Masters B.A., Kelly E.J., Quaife C.J., Brinster R.L., Palmiter R.D. Targeted disruption of metallothionein-I and metallothionein-II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA. 91:1994;584-588.
27. Michalska A.E., Choo K.H. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA. 90:1993;8088-8092.
28. Beattie J.H., Wood A.M., Newman A.M., Bremner I., Choo K.H., Michalska A.E., Duncan J.S., Trayhurn P. Obesity and hyperleptinemia in metallothionein (-I and-II) null mice. Proc Natl Acad Sci USA. 95:1998;358-363.
29. Beattie J.H., Black D.J., Wood A.M., Trayhurn P. Cold-induced expression of the metallothionein-1 gene in brown adipose tissue of rats. Am J Physiol. 270:1996;R971-R977.
30. Sato M., Apostolova M.D., Hamaya M., Yamaki J., Choo K.H.A., Michalska A.E., Kodama N., Tohyama C. Susceptibility of metallothionein-null mice to paraquat. Environ Toxicol Pharmacol. 1:1996;221-225.
31. Coyle P., Philcox J.C., Rofe A.M. Metallothionein-null mice absorb less Zn from an egg-white diet, but a similar amount from solutions, although with altered intertissue Zn distribution. J Nutr. 129:1999;372-379.
32. Coyle P., Philcox J.C., Rofe A.M. Hepatic zinc in metallothionein-null mice following zinc challenge - in vivo and in vitro studies. Biochem J. 309:1995;25-31.
33. Kelly E.J., Quaife C.J., Froelick G.J., Palmiter R.D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr. 126:1996;1782-1790.
34. Studer R., Vogt C.P., Cavigelli M., Hunziker P.E., Kägi J.H. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem J. 328:1997;63-67.
35. Nagel W.W., Vallee B.L. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci USA. 92:1995;579-583.
36. Schmidt C., Beyersmann D. Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells. Arch Biochem Biophys. 364:1999;91-98.
37. Suhy D.A., Simon K.D., Linzer D.I., O'Halloran T.V. Metallothionein is part of a zinc-scavenging mechanism for cell survival under conditions of extreme zinc deprivation. J Biol Chem. 274:1999;9183-9192. This paper presents evidence that MT plays a role in the maintenance of intracellular zinc levels. A detailed interpretation of these results regarding the role of MT in zinc homeostasis is given.
38. Roesijadi G., Bogumil R., VaÒák M., Kägi J.H. Modulation of DNA binding of a Tramtrack zinc finger peptide by the metallothionein-thionein conjugate pair. J Biol Chem. 273:1998;17425-17432.
39. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA. 95:1998;3489-3494.
40. Jiang L.J., Maret W., Vallee B.L. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc Natl Acad Sci USA. 95:1998;3483-3488.
41. 7-MT.
42. Deng D.X., Chakrabarti S., Waalkes M.P., Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma. Histopathology. 32:1998;340-347.
43. Kondo Y., Rusnak J.M., Hoyt D.G., Settineri C.E., Pitt B.R., Lazo J.S. Enhanced apoptosis in metallothionein null cells. Mol Pharmacol. 52:1997;195-201.
44. Tsangaris G.T., Tzortzatou-Stathopoulou F. Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Anticancer Res. 18:1998;2423-2433.
45. Abdel-Mageed A.B., Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4:1997;199-207.
46. Baichwal V.R., Baeuerle P.A. Apoptosis: activate NF-κB or die? Curr Biol. 7:1997;94-96.
47. Abdel-Mageed A.B., Agrawal K.C. Activation of nuclear factor kappa B: potential role in metallothionein-mediated mitogenic response. Cancer Res. 58:1998;2335-2338. This work shows a specific interaction of MT with the p50 subunit of NF-κB. These results open new horizons regarding the biological function of MTs.
48. Tsujikawa K., Suzuki N., Sagawa K., Itoh M., Sugiyama T., Kohama Y., Otaki N., Kimura M., Mimura T. Induction and subcellular-localization of metallothionein in regenerating rat-liver. Eur J Cell Biol. 63:1994;240-246.
49. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
50. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA. 89:1992;6333-6337.
51. Moffatt P., Seguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol. 17:1998;501-510.
52. Erickson J.C., Sewell A.K., Jensen L.T., Winge D.R., Palmiter R.D. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:1994;297-304.
53. Quaife C.J., Kelly E.J., Masters B.A., Brinster R.L., Palmiter R.D. Ectopic expression of metallothionein-III causes pancreatic acinar cell necrosis in transgenic mice. Toxicol Appl Pharmacol. 148:1998;148-157.
54. Amoureux M.C., Van Gool D., Herrero M.T., Dom R., Colpaert F.C., Pauwels P.J. Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired. Mol Chem Neuropathol. 32:1997;101-121.
55. Arai Y., Uchida Y., Takashima S. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome. Pediatr Neurol. 17:1997;134-138.
56. Bruinink A., Faller P., Sidler C., Bogumil R., VaÒák M. Growth inhibitory factor and zinc affect neural cell cultures in a tissue specific manner. Chem Biol Interact. 115:1998;167-174.
57. Sewell A.K., Jensen L.T., Erickson J.C., Palmiter R.D., Winge D.R. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry. 34:1995;4740-4747.
58. Bogumil R., Faller P., Binz P.A., VaÒák M., Charnock J.M., Garner C.D. Structural characterization of Cu(I) and Zn(II) sites in neuronal-growth-inhibitory factor by extended X-ray absorption fine structure (EXAFS). Eur J Biochem. 255:1998;172-177.
59. Faller P., VaÒák M. Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor. Biochemistry. 36:1997;13341-13348.
60. Hasler D.W., Faller P., VaÒák M. Metal-thiolate clusters in the C-terminal domain of human neuronal growth inhibitory factor (GIF). Biochemistry. 37:1998;14966-14973.
61. 7-GIF were interpreted as arising from dynamic processes caused by metal-thiolate cluster rearrangements.
62. Vallee B.L. The function of metallothionein. Neurochem Int. 27:1995;23-33.
63. Cramer P., Muller C.W. A firm hand on NFκB: structures of the Iκ Bα-NFκB complex. Structure. 7:1999;1-6.
64. 7]-metallothionein-1 by homonuclear NMR spectroscopy. Protein Sci. 8:1999;2630-2638.